(Q44593075)

4 December 2017

title

Compliance with pharmacologic therapy for osteoporosis (English)

1 reference

4 December 2017

0 references

1 reference

Srinivas Emani

2

1 reference

4 December 2017

Barbara Edelman Lewis

4

1 reference

4 December 2017

Mary Charpentier

5

1 reference

4 December 2017

Eva Lydick

6

1 reference

4 December 2017

Robert A. Yood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14504697

13 March 2024

John I. Reed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14504697

13 March 2024

language of work or name

English

0 references

publication date

19 September 2003

1 reference

full work available at URL

4 December 2017

http://link.springer.com/content/pdf/10.1007/s00198-003-1502-4.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00198-003-1502-4

http://link.springer.com/article/10.1007/s00198-003-1502-4/fulltext.html

13 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00198-003-1502-4

http://link.springer.com/content/pdf/10.1007/s00198-003-1502-4

13 March 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00198-003-1502-4

Osteoporosis International

13 March 2024

published in

1 reference

4 December 2017

volume

14

1 reference

4 December 2017

issue

12

1 reference

4 December 2017

page(s)

965-968

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-003-1502-4

4 December 2017

exact match

0 references

cites work

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

12 December 2020

Postmenopausal hormonal support: discontinuation of raloxifene versus estrogen

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI

1 reference

12 December 2020

Determinants of long-term hormone replacement therapy and reasons for early discontinuation

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

12 December 2020

Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy

1 reference

12 December 2020

Effect of age on reasons for initiation and discontinuation of hormone replacement therapy

1 reference

12 December 2020

How many women lose bone mineral density while taking hormone replacement therapy? Results from the Postmenopausal Estrogen/Progestin Interventions Trial.

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice

1 reference

12 December 2020

Identifiers

DOI

1 reference

release_7h34evxkvjff3ilwpkck7j7g54

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7h34evxkvjff3ilwpkck7j7g54

24 November 2022

mapped directly with Wikidata item

1 reference